Skip to main content
. Author manuscript; available in PMC: 2019 Jul 2.
Published in final edited form as: Mol Pharm. 2018 May 30;15(7):2606–2613. doi: 10.1021/acs.molpharmaceut.8b00133

Figure 2.

Figure 2

Results of the therapeutic study. (A) Average (±SD) tumor volumes for all groups over the 14 day study. (B) Kaplan–Meier survival curve. *p < 0.05 for 90Y-DTPA-TRC105 group as compared to all others, n = 5–6 per group.